Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac for Visual Outcomes after Multifocal IOL Implantation
NCT00433225Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketorolac in macular edema, sponsored by Janssen Pharmaceutical. Status: completed.
02
Drugs
ketorolac
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT00433225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433225.